# FDA Inspection 1160444 - Grifols Bio Supplies Inc - December 09, 2021

Source: https://www.keypedia.com/records/fda_inspections/grifols-bio-supplies-inc/2860d969-39fb-434c-b84b-3fc51bdce456
Source feed: FDA_Inspections

> FDA Inspection 1160444 for Grifols Bio Supplies Inc on December 09, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1160444
- Company Name: Grifols Bio Supplies Inc
- Inspection Date: 2021-12-09
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1160444 - 2021-12-09](https://www.keypedia.com/records/fda_inspections/grifols-bio-supplies-inc/202dc52f-b7b6-47f4-9442-bebb5eb1eff2)
- [FDA Inspection 1039870 - 2017-11-02](https://www.keypedia.com/records/fda_inspections/grifols-bio-supplies-inc/ed65e113-200a-40f0-999f-5430f3ecca07)

Company: https://www.keypedia.com/companies/grifols-bio-supplies-inc/44d9ebdf-341f-449b-8df3-ad895aab70dd

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d